Standard Bariatrics Patient Site – Patient-facing site for Standard Bariatrics, a Cincinnati-based surgical procedure company focused on the innovative development and commercialization of medical devices for the surgical treatment of obesity.

When it comes to bariatric surgery,

you have options.

NAVIGATE TO:

Who qualifies for
bariatric surgery?

Obesity is a complex health issue. For some people, the most effective solution is bariatric surgery. 

The American Society for Metabolic and Bariatric Surgery (ASMBS) explains that metabolic or bariatric surgery is a highly effective, long-lasting treatment for severe obesity. In addition to substantial weight loss, it may also improve, prevent, or resolve obesity-related conditions, such as type 2 diabetes, heart disease, high blood pressure, sleep apnea, and some types of cancer.¹

You may be a candidate for bariatric surgery if you have:¹

A BMI ≥35 kg/m² with or without co-morbid conditions that may or may not be severe
Type 2 diabetes and a BMI ≥30 kg/m²
A BMI of 30–34.9 kg/m² and have not achieved appropriate weight loss or improvement in co-morbid conditions with nonsurgical methods

There are risks associated with bariatric surgery as with any major procedure. In bariatric procedures, potential risks after surgery may include infection, bleeding, respiratory issues, gastrointestinal leaks, blood clots, and, in rare cases, death.²

Review the potential risks and benefits with your doctor to determine if bariatric surgery is right for you.

Types of Bariatric Surgery

Gastric sleeve is a procedure where the surgeon reduces the stomach by about 80%, leaving a “sleeve” of stomach. No other changes are made to the intestines or digestive system.

Gastric bypass, also known as Roux-en-Y (roo-en-wy), is a procedure where the surgeon reduces the stomach to a small pouch which is then connected directly to the small intestine.

SADI-S, also known as a single anastomosis duodeno-ileal bypass with sleeve gastrectomy, is a procedure where the surgeon performs a sleeve gastrectomy as well as makes one change to the intestines. This surgery reduces the stomach size and impacts the body’s ability to absorb nutrients and calories.

BPD/DS, also known as biliopancreatic diversion with duodenal switch, is a procedure where the surgeon performs a sleeve gastrectomy as well as makes two changes to the intestines. This surgery reduces the stomach size and highly impacts the body’s ability to absorb nutrients and calories.

Malabsorptive bariatric procedures work by limiting the body’s ability to absorb calories, proteins, and nutrients, while restrictive procedures focus on reducing the amount of food consumed and enhancing the sense of fullness after eating.¹

The basics about gastric sleeve.

In most bariatric procedures, the size of the stomach is often significantly reduced or a sleeve pouch anatomy is created.

The gastric sleeve is the most popular weight loss surgery both in the U.S. and the world. Each year, over half of the bariatric surgeries in the U.S. are sleeve gastrectomies, with approximately 150,000 performed nationwide and 380,000 performed worldwide.³

In a sleeve gastrectomy procedure, surgical staplers are used to remove 80% of the stomach, making it much smaller. This reduces the amount of food and liquid the stomach can hold, which helps decrease the amount of calories consumed.¹

Potential benefits of the Titan SGS™ Stapler in sleeve gastrectomy.*

*Retrospective data may not be indicative of clinical performance. Individual results may vary.

The Titan SGS™ Stapler is designed to create a consistent, symmetrical sleeve gastrectomy in a single, continuous staple line with only one deployment.⁴ The approach may contribute to a reduced chance of post-operative complications and shorter hospital stay compared to multi-fire staplers.^5,8-11

As the only commercially available U.S. stapler specifically designed for gastric sleeve pouch creation,^4,6 the Titan SGS™ Stapler has been used  in more than 20,000 procedures.⁷

Less nausea.⁸ At 30 days after surgery, 9.2% (72 patients) who had laparoscopic sleeve gastrectomy with the Titan SGS™ Stapler experienced nausea or vomiting, compared to 10.6% (83 patients) with multi-fire staplers (p=0.36).^8*

Improved GERD resolution.⁹ 25% of Titan SGS™ Stapler patients who had GERD prior to surgery no longer had GERD 1 year post-op, compared to 10.9% who had a sleeve gastrectomy using multi-fire staplers (p=0.005).^9*

Quicker procedure.^4,10,11 Titan SGS™ Stapler completes stapling in about 55 seconds⁴ — 90% faster than the average stapler^† — which may help reduce surgery time.¹¹

† Based on an indirect comparison of operative technique for gastric stapling in the cited published literature for sleeve gastrectomies performed utilizing Covidien and Ethicon Endo-Surgery staplers.

Shorter hospital stay.⁸ Patients were more likely to be discharged within 24 hours after surgery when the Titan SGS™ Stapler was used for laparoscopic sleeve gastrectomy [89.6%, 702 patients], compared to multi-fire staplers [65.0%, 509 patients].^8*

Find a provider

Talk with your doctor about bariatric surgery and if sleeve gastrectomy with the Titan SGS™ Stapler might be right for you.

American Society for Metabolic and Bariatric Surgery. Bariatric Surgery Procedures. Accessed November 28, 2024. https://asmbs.org/.
Mayo Clinic. Bariatric surgery: what you need to know. Accessed November 28, 2024. https://www.mayoclinic.org/testsprocedures/bariatric-surgery/ about/pac-20394258.
Cleveland Clinic. Gastric sleeve surgery. Accessed October 28, 2024. https:// my.clevelandclinic.org/health/treatments/22931-gastric-sleeve-surgery.
U.S. Food and Drug Administration. 510(k) Premarket Notification: K210278. Published April 28, 2021.
Standard Bariatrics Inc. Multisite comparative analysis of Titan SGS™ Stapler to existing surgical staplers in sleeve gastrectomy; 2022. Unpublished raw data. Qualitee 360 Report. Retrieved from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database.
Teleflex Incorporated. Data on File. Search of FDA cleared product code GDW through February 2025.
Teleflex Incorporated. Data on file: sales unit data from product release through July 5, 2025.
Fritz GD, Sharrak A, Aubrey J, et al. Perioperative outcomes using single-fire stapler. Obes Surg. 2024;34(9):3553-3560. doi:10.1007/s11695-024-07357-4.*
Ying L, Rutledge R, Butensky S, Farinas Lugo D, Morton JM, Ringold F. Does stapling platform influence robotic sleeve gastrectomy postoperative outcomes?  Obes Surg. 2025;35(4). doi:10.1007/s11695-025-07855-z.*
Salyer CE, Thompson J, Hoffman A, Burstein MD, Enochs P, Watkins BM, Kuethe J, Goodman MD. Multisite study of Titan SGS Stapler in longitudinal gastric resection. Surg Endosc. 2022. doi:10.1007/s00464-022-09051-x.
Varban OA, Niemann A, Stricklen A, Ross R, Ghaferi AA, Finks JF, Dimick JB. Far from standardized: using surgical videos to identify variation in technique for laparoscopic sleeve gastrectomy. J Laparoendosc Adv Surg Tech A. 2017;27(8):761-767. doi:10.1089/lap.2017.0184

*Drs. Schram, Foote, authors of the Fritz et al. study and Drs. Morton and Ringold, authors of Ying et al. study, are paid consultants of Teleflex.

Rx only.

The information included on this website is for educational and informational purposes only and should not be used as a substitute for talking to your doctor. Patients should always consult with their doctor about diagnosis or treatment information.

Refer to package insert provided with the product for complete warnings, indications, contraindications, precautions, potential complications and instructions for use.

Teleflex, the Teleflex logo, Standard Bariatrics, and Titan SGS are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are the property of their respective owners and are solely used for identification purposes and do not imply any affiliation, endorsement, or ownership by Teleflex Incorporated or its affiliates.